Company intelligence / Profile preview

MedicAir

Leamington Spa, United Kingdommedicairhealth.it ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

MedicAir’s air purifiers are trusted by the NHS and WHO for infection control during COVID-19. The devices use HEPA filtration combined with UV-C sterilization to remove 99.99% of airborne viruses and bacteria from indoor environments such as hospitals, clinics, offices, schools, and homes.

Therapeutic areas: PulmonologyInfectious Diseases
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

NHS (UK National Health Service)WHO

Beyond the preview

Go deeper on MedicAir.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedicAir.

Explore the full profile